Changes in the expression of individual components of the APP machinery have been associated with the lack or reduced presentation of tumor antigens, as well as variation in the level of tumor-infiltrating CD8+ T cells and response to ICI-based therapy (17–19). This evidence concerns the gene APP and neoplasm.